Alessandra Longobardi, Roberto Buonaiuto, Aldo Caltavituro, Giuseppina Crimaldi, Vincenza Cantile, Vittoria Molinaro, Federica P. Mangiacotti, Angela Grieco, Martina Di Meo, Martina Pagliuca, Valeria Forestieri, Mario Giuliano, Michelino De Laurentiis, Grazia Arpino, Carmine De Angelis. "Evaluating the benefit-risk balance of second-line therapies for HR+/HER2- metastatic breast cancer: A comparative analysis using ASCO VF and ESMO MCBS frameworks.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e13100